G. Villa

First name
G.
Last name
Villa
Danese, M., Sidelnikov, E., Villa, G., Catterick, D., Iqbal, M., Gleeson, M., et al. (2022). Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK. Bmj Open, 12, e055015. http://doi.org/10.1136/bmjopen-2021-055015
Toth, P. P., Danese, M., Villa, G., Qian, Y., Beaubrun, A., Lira, A., & Jansen, J. P. (2017). Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context. J Med Econ. http://doi.org/10.1080/13696998.2017.1284078
Danese, M. D., Pemberton-Ross, P., Catterick, D., & Villa, G. (2020). Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom. Eur J Prev Cardiol. http://doi.org/10.1177/2047487319899212
Danese, M. D., Pemberton-Ross, P., Catterick, D., & Villa, G. (2021). Estimation of the increased risk associated with recurrent events or polyvascular atherosclerotic cardiovascular disease in the United Kingdom. Eur J Prev Cardiol. http://doi.org/10.1177/2047487319899212